Przewlekła niewydolność serca: badanie fazy III leku BI 690517 i empagliflozin
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart